Next week, on May 31 in American and June 1 in Europe, we will be discussing the two major AKI studies looking at the timing of renal replacement therapy:
Look for a formal background post later this week.
This week, we will discuss the ongoing saga of blood pressure targets in patients with hypertension. This time its ESPRIT (Effects of Intensive Systolic Blood Pressure Lowering Treatment in Reducing Risk of Vascular Events) making a case for case for intensive BP control in most hypertensive individuals, including those with a history of diabetes and stroke.
Next week, on May 31 in American and June 1 in Europe, we will be discussing the two major AKI studies looking at the timing of renal replacement therapy:
AKIKI https://t.co/HbpI0AkhPj
— Graham Abra, MD (@GrahamAbra) May 22, 2016
Vs
ELAINhttps://t.co/RVqRSDPm1c
Fight!
Look for a formal background post later this week.